Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Benchmark Downgrades National CineMedia to Hold

Benchmark Downgrades National CineMedia to Hold

Benchmark analyst Mike Hickey downgrades National CineMedia (NASDAQ:NCMI) from Buy to Hold.

byBenzinga Newsdesk

October 3, 2022

1 minute read

Benchmark analyst Mike Hickey downgrades National CineMedia (NASDAQ:NCMI) from Buy to Hold.

First Republic Bank Stock Is Falling: What’s Going On?

By Adam Eckert

April 10, 9:18 AM

First Republic Bank (NYSE: FRC) shares are trading lower Monday after the company suspended dividend payments on its preferred stock.

FRC

BridgeBio Starts Dosing In Early-Stage Genetic Metabolism Disorder Trial

By Vandana Singh

August 18, 8:53 AM

BridgeBio Pharma Inc (NASDAQ:BBIO) has dosed the first patient in its Phase 1 trial of BBP-671, an investigational oral therapy for…

BBIO

GlucoTrack Announces Preclinical Testing With Implantable Continuous Glucose Monitor

By Benzinga Newsdesk

October 12, 8:37 AM

Glucotrack, Inc. (NASDAQ:GCTK) ("Glucotrack" or the "Company"), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today that it has achieved another

GCTK

Goldman Sachs Downgrades Reliance Steel & Aluminum to Neutral, Lowers Price Target to $201

By Benzinga Newsdesk

October 6, 4:55 AM

Goldman Sachs analyst Emily Chieng downgrades Reliance Steel & Aluminum (NYSE:RS) from Buy to Neutral and lowers the price target from $218 to $201.

Benchmark Downgrades National CineMedia to Hold

Related Posts

First Republic Bank Stock Is Falling: What’s Going On?

BridgeBio Starts Dosing In Early-Stage Genetic Metabolism Disorder Trial

GlucoTrack Announces Preclinical Testing With Implantable Continuous Glucose Monitor

Goldman Sachs Downgrades Reliance Steel & Aluminum to Neutral, Lowers Price Target to $201